Home > Boards > US Listed > Telecommunications Hardware > Terayon Communication Systems (TERN)

No i didn't give up. There just isn't

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
SEBASS Member Profile
 
Followed By 5
Posts 792
Boards Moderated 0
Alias Born 01/26/05
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/19/2022 4:11:00 PM
Terns Pharmaceuticals Appoints Jeffrey R. Jasper, Ph.D., as Senior Vice President, Head of Research and Promotes Diana Chung to Senior Vice President, Chief Development Officer GlobeNewswire Inc. - 1/6/2022 7:05:00 AM
Terns Pharmaceuticals to Present at 40th Annual J.P. Morgan Health Care Conference GlobeNewswire Inc. - 1/3/2022 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 4:58:55 PM
Terns Pharmaceuticals EPS beats by $0.13 Seeking Alpha - 11/15/2021 4:53:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 4:38:18 PM
Terns Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights GlobeNewswire Inc. - 11/15/2021 4:05:00 PM
Terns Pharmaceuticals Highlights Positive Clinical Data from Multiple NASH Programs at AASLD The Liver Meeting® Digital Experience 2021 GlobeNewswire Inc. - 11/12/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 4:55:02 PM
Terns Reports Positive Top-line Results from Phase 1 Proof of Concept Clinical Trial of THR-β agonist TERN-501 GlobeNewswire Inc. - 11/9/2021 4:05:00 PM
Terns Pharmaceuticals to Present Positive Clinical Data on NASH Programs at AASLD The Liver Meeting® Digital Experience 2021 GlobeNewswire Inc. - 10/18/2021 4:05:00 PM
Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference GlobeNewswire Inc. - 10/5/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2021 6:03:47 AM
Terns Appoints Veteran Biopharmaceutical Executive Ann E. Taylor, M.D. to Board of Directors GlobeNewswire Inc. - 9/28/2021 4:05:00 PM
Goldman Sachs Sees These 2 Stocks Surging Over 70% TipRanks - 9/15/2021 6:07:42 PM
Terns Completes Part 1 Enrollment of AVIATION Phase 1b NASH Clinical Trial of VAP-1 Inhibitor TERN-201 GlobeNewswire Inc. - 9/8/2021 7:05:00 AM
Terns Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 9/2/2021 4:05:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:44:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 4:26:04 PM
Terns Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights GlobeNewswire Inc. - 8/16/2021 4:05:00 PM
Terns Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 8/3/2021 4:05:00 PM
Terns Pharmaceuticals doses first patient in early-stage TERN-201 NASH study Seeking Alpha - 6/24/2021 4:11:37 PM
Terns Announces Initiation of Patient Dosing in AVIATION Phase 1b NASH Clinical Trial of VAP-1 Inhibitor TERN-201 GlobeNewswire Inc. - 6/24/2021 4:05:00 PM
Terns Pharmaceuticals up 9% on positive phase 2 NASH data Seeking Alpha - 6/14/2021 8:42:34 AM
Terns Pharma gains 9% on positive TERN-101 data in mid-stage NASH study Seeking Alpha - 6/14/2021 8:12:23 AM
SEBASS   Thursday, 02/01/07 03:05:56 PM
Re: followinsnsr post# 320
Post # of 329 
No i didn't give up. There just isn't too many posters so it's just slow. Co should be bought out in Feb/Mar hopefully not in May. I held if for a year already so to me the quicker the better, but it's personal thing. Good luck buddy.

And as Jack always says: "You can't handle the truth! Son"

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences